CY1786A - Use of buspirone for preparing pharmaceutical compositions for alleviation of phobic anxiety - Google Patents

Use of buspirone for preparing pharmaceutical compositions for alleviation of phobic anxiety

Info

Publication number
CY1786A
CY1786A CY178695A CY178695A CY1786A CY 1786 A CY1786 A CY 1786A CY 178695 A CY178695 A CY 178695A CY 178695 A CY178695 A CY 178695A CY 1786 A CY1786 A CY 1786A
Authority
CY
Cyprus
Prior art keywords
buspirone
alleviation
pharmaceutical compositions
preparing pharmaceutical
phobic anxiety
Prior art date
Application number
CY178695A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CY1786A publication Critical patent/CY1786A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
CY178695A 1985-10-25 1995-10-20 Use of buspirone for preparing pharmaceutical compositions for alleviation of phobic anxiety CY1786A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/791,182 US4634703A (en) 1985-10-25 1985-10-25 Method for alleviation of panic disorders

Publications (1)

Publication Number Publication Date
CY1786A true CY1786A (en) 1995-10-20

Family

ID=25152914

Family Applications (1)

Application Number Title Priority Date Filing Date
CY178695A CY1786A (en) 1985-10-25 1995-10-20 Use of buspirone for preparing pharmaceutical compositions for alleviation of phobic anxiety

Country Status (11)

Country Link
US (1) US4634703A (de)
EP (1) EP0220696B1 (de)
JP (1) JPH0667841B2 (de)
AT (1) ATE86858T1 (de)
AU (1) AU592121B2 (de)
CY (1) CY1786A (de)
DE (1) DE3688038T2 (de)
ES (1) ES2053429T3 (de)
GR (1) GR3007393T3 (de)
HK (1) HK87094A (de)
ZA (1) ZA867670B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777173A (en) * 1987-03-25 1988-10-11 Bristol-Myers Company Method for treatment of alcohol abuse
US4782060A (en) * 1987-07-29 1988-11-01 Bristol-Myers Company Gepirone for alleviation of panic disorders
SE8704097D0 (sv) * 1987-10-22 1987-10-22 Astra Ab Oral formulation of buspirone and salts thereof
DE3736974A1 (de) * 1987-10-31 1989-05-11 Troponwerke Gmbh & Co Kg Verwendung von 2-pyrimidinyl-1-piperazin-derivaten
US5468749A (en) * 1988-08-30 1995-11-21 Gawin; Frank H. Method for treatment of substance addiction
US6432956B1 (en) 1990-02-12 2002-08-13 William C. Dement Method for treatment of sleep apneas
US5166202A (en) * 1990-09-19 1992-11-24 Trustees Of The University Of Pennsylvania Method for the treatment of panic disorder
US5633009A (en) * 1990-11-28 1997-05-27 Sano Corporation Transdermal administration of azapirones
JPH04327532A (ja) * 1991-01-31 1992-11-17 Bristol Myers Squibb Co 活動過剰を伴う注意力欠乏疾患の治療に使用する医薬製剤
US5431922A (en) * 1991-03-05 1995-07-11 Bristol-Myers Squibb Company Method for administration of buspirone
US5457100A (en) * 1991-12-02 1995-10-10 Daniel; David G. Method for treatment of recurrent paroxysmal neuropsychiatric
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
WO1994002623A1 (en) * 1992-07-15 1994-02-03 University Of South Florida Blood levels of cck peptides relative to panic disorder treatment
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
JP3688293B2 (ja) * 1993-09-29 2005-08-24 アルザ・コーポレーション モノグリセリド／乳酸エステル透過促進剤
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
GB9706089D0 (en) * 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
US8134029B2 (en) * 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
US7588732B2 (en) * 2004-03-30 2009-09-15 Genesis Biosystems, Inc. Autologus tissue harvesting and irrigation device
JP2009500425A (ja) 2005-07-06 2009-01-08 セプラコア インコーポレーテッド エスゾピクロン及びトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−ｎ−メチル−１−ナフタレンアミン又はトランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミンの組み合わせ、並びに閉経期並びに気分、不安、及び認知障害の治療方法
DK2816024T3 (en) 2006-03-31 2017-10-30 Sunovion Pharmaceuticals Inc CHIRALE AMINER
EP2076288A2 (de) * 2006-09-22 2009-07-08 Braincells, Inc. Kombination aus einem hmg-coa-reduktasehemmer und einem zweiten neurogenen wirkstoff zur behandlung einer nervensystemerkrankung und erhöhung von neurogenese
JP2012526832A (ja) * 2009-05-13 2012-11-01 スノビオン プハルマセウトイカルス インコーポレイテッド トランスノルセルトラリン及びセロトニン受容体１ａ作動剤／拮抗剤を含む組成物及びその使用
RU2660583C1 (ru) * 2017-08-15 2018-07-06 Общество С Ограниченной Ответственностью "Валента - Интеллект" Применение буспирона для лечения функционального головокружения

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987052A (en) * 1969-03-17 1976-10-19 The Upjohn Company 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4508726A (en) * 1982-09-16 1985-04-02 The Upjohn Company Treatment of panic disorders with alprazolam
US4438119A (en) * 1982-12-23 1984-03-20 Mead Johnson & Company Method for alleviation of extrapyramidal motor disorders

Also Published As

Publication number Publication date
EP0220696B1 (de) 1993-03-17
AU592121B2 (en) 1990-01-04
ATE86858T1 (de) 1993-04-15
US4634703A (en) 1987-01-06
EP0220696A2 (de) 1987-05-06
JPS62111924A (ja) 1987-05-22
EP0220696A3 (en) 1989-10-04
JPH0667841B2 (ja) 1994-08-31
DE3688038T2 (de) 1993-07-01
DE3688038D1 (de) 1993-04-22
HK87094A (en) 1994-09-02
AU6424586A (en) 1987-04-30
GR3007393T3 (de) 1993-07-30
ZA867670B (en) 1987-06-24
ES2053429T3 (es) 1994-08-01

Similar Documents

Publication Publication Date Title
CY1786A (en) Use of buspirone for preparing pharmaceutical compositions for alleviation of phobic anxiety
AR240251A1 (es) Metodo para preparar una composicion para tratamiento de infecciones virales y un metodo para sintetizar 3' azido 2', 3' dideoxiuridina destinada a la preparacion de dicha composicion.
IE862554L (en) Pharmaceutical compositions
HUT46654A (en) Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient
IT8449031A0 (it) Impiego in terapia di composti di trasferimento di metilolo,relative composizioni farmaceutiche e procedimento per preparare queste
GB8904163D0 (en) Piperazine derivative or its sait,process for producing the same and pharmaceutical composition comprising the same as active ingredient
NZ224189A (en) 6-substituted 2',3'-dideoxynucleosides and pharmaceutical compositions
IT8419308A0 (it) Procedimento per la preparazione di formulazioni galeniche particolarmente per uso farmaceutico, dietetico, cosmetico e diagnostico.
EP0282818A3 (en) The use of gepirone for preparing a pharmaceutical composition for alleviation of primary depressive disorders
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
IT8419950A0 (it) Contengono i prodotti emichetali di (8s)-8-fluoroeritromi cine, il procedimento per la loro preparazione e le formulazioni adatte alla somministrazione orale che
HUT46660A (en) Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient
IT9019914A0 (it) Composti immunogenici,il procedimento per la loro sintesi e loro impiego per la preparazione di vaccini antimalaria
HUT63151A (en) Process for producing new benzimidazole-2-sulfonamide and imidazopyuridine-2-sylfonamide derivatives, as well as pharmaceutical compositions comprising same as active ingredient
NO900643L (no) Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater.
IT9020020A0 (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
EP0301239A3 (en) Use of gepirone for preparing pharmaceutical compositions for alleviation of panic disorders
IT1194158B (it) Carbacicline,procedimento per la loro preparazione e loro impiego come medicinali
IT1186754B (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8 fenil-10 antrone-9,e procedimento di preparazione dell'ingrediente attivo
IT8620703A0 (it) Derivati dell'acido 4-fenil 4-osso 2-butenoico, loro procedimento di preparazione e loro impiego come prodotti medicinali.
IT1187655B (it) Procedimento per la preparazione di w-lattami,in particolare caprolattame
FI871479A0 (fi) Menetelmä lääkeaineina käyttökelpoisten perhydrotiatsepiini- ja perhydroatsepiinijohdannaisten valmistamiseksi
NO894516L (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
GB2185478B (en) Novel e-valerolactam, pharmacologically active compositions thereof, processes for the preparation thereof and their medical use
IT8720271A0 (it) Nuovi derivati dell'ergolene, composizioni farmaceutiche che licontengono e procedimento per lapreparazione dei medesimi.